Henry Schein EBITDA Margin 2010-2024 | HSIC

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Henry Schein (HSIC) over the last 10 years. The current EBITDA margin for Henry Schein as of December 31, 2024 is .
Henry Schein EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-12-31 $12.67B $0.93B 7.34%
2024-09-30 $12.50B $0.82B 6.57%
2024-06-30 $12.49B $0.86B 6.88%
2024-03-31 $12.45B $0.89B 7.12%
2023-12-31 $12.34B $0.89B 7.21%
2023-09-30 $12.69B $0.88B 6.93%
2023-06-30 $12.60B $0.87B 6.94%
2023-03-31 $12.53B $0.89B 7.08%
2022-12-31 $12.65B $0.96B 7.58%
2022-09-30 $12.61B $1.10B 8.69%
2022-06-30 $12.72B $1.10B 8.61%
2022-03-31 $12.66B $1.08B 8.55%
2021-12-31 $12.40B $1.06B 8.56%
2021-09-30 $12.24B $1.03B 8.42%
2021-06-30 $11.90B $1.00B 8.40%
2021-03-31 $10.62B $0.78B 7.34%
2020-12-31 $10.12B $0.72B 7.13%
2020-09-30 $9.62B $0.74B 7.67%
2020-06-30 $9.29B $0.74B 7.96%
2020-03-31 $10.06B $0.91B 9.06%
2019-12-31 $9.99B $0.90B 9.04%
2019-09-30 $9.79B $0.85B 8.71%
2019-06-30 $9.64B $0.78B 8.07%
2019-03-31 $9.51B $0.76B 8.00%
2018-12-31 $9.42B $0.75B 7.91%
2018-09-30 $6.69B $0.59B 8.89%
2018-06-30 $7.49B $0.70B 9.31%
2018-03-31 $8.23B $0.76B 9.26%
2017-12-31 $8.88B $0.80B 9.04%
2017-09-30 $12.26B $1.02B 8.29%
2017-06-30 $11.97B $1.00B 8.34%
2017-03-31 $11.78B $0.96B 8.17%
2016-12-31 $11.57B $0.94B 8.13%
2016-09-30 $11.30B $0.92B 8.18%
2016-06-30 $11.12B $0.91B 8.21%
2016-03-31 $10.88B $0.91B 8.38%
2015-12-31 $10.63B $0.89B 8.41%
2015-09-30 $10.48B $0.90B 8.55%
2015-06-30 $10.42B $0.88B 8.42%
2015-03-31 $10.41B $0.87B 8.39%
2014-12-31 $10.37B $0.87B 8.36%
2014-09-30 $10.20B $0.84B 8.27%
2014-06-30 $9.92B $0.82B 8.29%
2014-03-31 $9.70B $0.81B 8.37%
2013-12-31 $9.56B $0.81B 8.48%
2013-09-30 $9.44B $0.81B 8.55%
2013-06-30 $9.33B $0.80B 8.53%
2013-03-31 $9.13B $0.77B 8.46%
2012-12-31 $8.94B $0.75B 8.33%
2012-09-30 $8.87B $0.72B 8.15%
2012-06-30 $8.75B $0.72B 8.17%
2012-03-31 $8.68B $0.71B 8.17%
2011-12-31 $8.53B $0.70B 8.18%
2011-09-30 $8.22B $0.67B 8.19%
2011-06-30 $8.00B $0.66B 8.30%
2011-03-31 $7.72B $0.65B 8.41%
2010-12-31 $7.53B $0.63B 8.32%
2010-09-30 $7.29B $0.62B 8.48%
2010-06-30 $7.05B $0.59B 8.38%
2010-03-31 $6.81B $0.57B 8.37%
2009-12-31 $6.54B $0.55B 8.44%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $7.960B $12.673B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.331B 24.44
Becton Dickinson (BDX) United States $59.463B 14.89
Cardinal Health (CAH) United States $34.131B 18.28
Labcorp (LH) United States $20.165B 16.36
Straumann Holding AG (SAUHY) Switzerland $19.326B 0.00
Cooper (COO) United States $16.332B 21.66
West Pharmaceutical Services (WST) United States $15.180B 31.82
Align Technology (ALGN) United States $12.687B 24.93
Merit Medical Systems (MMSI) United States $5.582B 26.99
DENTSPLY SIRONA (XRAY) United States $2.770B 8.32
CONMED (CNMD) United States $1.519B 11.37
STAAR Surgical (STAA) United States $0.904B 0.00
Pro-Dex (PDEX) United States $0.214B 32.68
Lifevantage (LFVN) United States $0.155B 17.18